Bowhead Specialty acquired by American Family Mutual Insurance: fairness opinion
Announced August 3, 2026 · Merger ·
SC 13E3 filed August 31, 2026
Enterprise value
$1.2B
EV / LTM EBITDA
15.2x
EBITDA $78.7M · 13% margin
EV / LTM revenue
1.96x
revenue $612M
DCF discount rate
7.5%–11.5%
Deal terms
Consideration—
Price per share—
Premium—
Premium basis—
StructureMerger
Termination fee—
Reverse termination fee—
Go-shopNone
Outside date—
FilingSC 13E3 · EDGAR index
3,000+ healthcare deal-level valuation multiples
The Valuation database includes financial details for more than 3,000 healthcare M&A transactions, private and public, with deal-level multiples, categorized by segment, type, and year.
Management projections
| Projection year | Year 1 | Year 2 | Year 3 | CAGR |
|---|---|---|---|---|
| Revenue | $672M | $781M | $926M | 17.4% |
| Revenue growth | 9.8% | 16.2% | 18.5% | |
| EBITDA | — | — | — | — |
| EBITDA growth | — | — | — | |
| EBITDA margin | — | — | — | |
| Implied EV / EBITDA | — | — | — |
Year-1 growth is against LTM at announcement ($612M revenue, $78.7M EBITDA); later years are year over year.
Other Outsourced Services fairness opinions
- Cross Country Healthcare / Knox Lane 2026 · 16.3x EV/EBITDA
- Premier / Patient Square Capital 2025 · 10.9x EV/EBITDA
- ProAssurance / The Doctors 2025 · 12.4x EV/EBITDA
- R1 RCM / TowerBrook and CD&R 2024 · 13.6x EV/EBITDA
- Stericycle / Waste Management 2024 · 15.1x EV/EBITDA
- Cross Country Healthcare / Aya Healthcare 2024 · 12.1x EV/EBITDA